background image

Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Find clinical trials for non-alcoholic steatohepatitis (nash). Search for non-alcoholic steatohepatitis (nash) clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: South Dartmouth MA, New Haven CT, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Russells Mills MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

for
Obesity, Non-Alcoholic Fatty Liver Disease,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70

Code: NCT06571474

Recruiting
Active & Responsive

Fibrosis Lessens After Metabolic Surgery

for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD),
Location: Cleveland OH
Sponsor: Ali Aminian

Sex: All

Age: 18 - 70+

Code: NCT06374875

Recruiting

A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

for
Non-Alcoholic Steatohepatitis (NASH)
Location: Secaucus NJ
Sponsor: Hepanova Inc.

Sex: All

Age: 18 - 55

Code: NCT04481594

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

for
Nonalcoholic Steatohepatitis (NASH),
Location: Columbia MO
Sponsor: Corcept Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06947304

Phase1, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Burlington MA, East Greenwich RI, Carmel NY,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Burlington MA, East Greenwich RI, New York NY,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

for
Nonalcoholic Fatty Liver Disease (NAFLD),
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03572465

Recruiting

Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study

for
Nonalcoholic Fatty Liver Disease
Location: Providence RI
Sponsor: Lifespan

Sex: All

Age: 18+

Code: NCT02469272

Phase1, Recruiting